OptiMedica Corporation is a medical device company dedicated to working with ophthalmologists to evolve standards of care which provide significant benefits to both physicians and patients.
Located in Santa Clara, California, OptiMedica was founded in January 2004 to rapidly incubate and introduce the PASCAL Photocoagulator, a radically new technology initially developed at Stanford University and exclusively licensed to OptiMedica.
The founding team is composed of experienced professionals from the medical laser industry, assisted by a renowned medical advisory board composed of retinal disease treatment thought leaders. OptiMedica has secured funding from Kleiner, Perkins, Caufield & Byers and Alloy Venture Partners. – less–ZoomInfo